Cardiovascular medicine

How can you adequately honor a man of deeds with mere words?

Few advances in cardiovascular medicine have so captured the inter- est of physicians and the public alike as has coronary artery bypass surgery.

As longevity increases, the scope of cardiac disorders extends more widely in the sixth decade and onward into the seventh and subse- quent decades.

This monograph summarizes the results of a fifteen-year vascular pathology research project sponsored by the Hungarian Academy of Sciences.

Substantial progress toward reconciling disparate theories of the pathogenesis of arteriosclerosis was recorded in Volume I of this book.

The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format.

a comprehensive and real picture of the complexities of ischemic heart disease, both to the person who deals in day to day practice with its problems, as well as to the This book presents a comprehensive picture of is- chemic heart disease to those who, either as practition- student and resident who tries to develop firm concepts ers or students, deal with the varied facets of this com- regarding the varied states observed in this common plex subject.

A variety of cardiovascular illnesses are now being encountered with surprising frequency in many general adult medical practices.

In Atlas of Nuclear Cardiology, Doctors Dilsizian and Narula have worked together with over a dozen leading authorities to capture the most up-to-date and pertinent information in the field of nuclear cardiology.

In this edition of the Atlas of Hypertension, Dr.

In its third edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome.

We are in the early years of a new millen- Tremendous interest is now focused on nium and atherosclerotic disease is now the characteristics of atherosclerotic thought to underlie more adult deaths plaques, as we recognize that many clinical than any other disease on the planet.

HE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, or T"e;lCD,"e; is arguably the most technologically challenging type of therapy that physicians utilize today.

In this book, the importance and value of accurately assessing coronary stenosis morphology is reviewed, including recent thoughts regarding the pathogenetic mechanisms ascribed to angiographically assessed morphology, several new and potentially more accurate means of determining plaque composition and its relationship to stenosis morphology, and the latest hypotheses regarding interventional device selection.

The goal of gene transfer is protein expression.

Heat shock proteins (HSP) were originally described in heat-shocked drosophila by Ritossa in the early 1960's.

For over a quarter of a century, echocardiography has made an unparalleled contribution to clinical cardiology as a major tool for real-time imaging of cardiac dynamics.

Angioplasty has completely transformed the treatment of coronary artery disease and is widely used, with more than 800,000 procedures performed worldwide per year.

Cardiovascular disease affects 20% of all Americans and is the leading cause of death in the USA.

Endocrinology of Cardiovascular Function is a fitting inauguration to the Endocrine Update Series.

In Heart Cell Communication in Health and Disease an extensive review of different aspects of heart cell communication is presented.

Non-Invasive Imaging of Atherosclerosis is a primer, reference and review of some of the key features of current activities in the field of atherosclerosis.

Currently blood is a volatile issue.

The last five years have witnessed an increasing interest in the subject of transmyocardial laser revascularization (TMR) as illustrated by the number of abstracts presented at the meetings of the American Heart Association and the American College of Cardiology (Figure).

Despite recent advances in the diagnosis and treatment of various cardiac illnesses, including ischemic, valvular and cardiomyopathic disease, the most cost-effective means of employing laboratory testing and treatment modalities remains an issue in most practice settings.

Molecular Cardiology for the Cardiologist, Second Edition provides a short, easily readable summary of what the new biology brings to cardiology.

Growth Hormone is a fitting addition to the Endocrine Updates Series.

This book is timely and challenging.

The publication embodied here represents the life work of a premier Russian scientist studying Sudden Cardiac Death.

Hypoxia is a constant threat throughout life.

One of the major biomedical triumphs of the post-World War II era was the defmitive demonstration that hypercholesterolemia is a key causative factor in atherosclerosis; that hypercholesterolemia can be effectively treated; and that treatment significantly reduces not only coronary disease mortality but also all- cause mortality.

Accurate diagnosis of arrhythmias is the goal of this volume.

Cardiac disease is the major cause of death in dialysis patients, accounting for over one third of deaths.

The cardiac system represents one of the most exciting challenges to human ingenuity.

Interventional cardiology is a creative, innovative, and rapidly advancing frontier of cardiology.

The molecular basis for atrial fibrillation continues to be largely unknown, and therapy remains unchanged, aimed at controlling the heart rate and preventing systemic emboli with anticoagulation.

Few complications of systemic diseases are better understood than diabetic nephropathy.

Whenever the heart is challenged with an increased work load for a prolonged period, it responds by increasing its muscle mass--a phenomenon known as cardiac hypertrophy.

This book is an attempt to indicate to researchers and clinicians a simple way to approach the complexity of cardiovascular neural regulation.

Each year over 400,000 people have a new onset of heart failure in the United States, adding to a current patient population of over 4.

Traditional methods of medical education and training are changing rapidly.